Otsuka Holdings
4578.T
#748
Rank
C$45.65 B
Marketcap
C$86.44
Share price
2.56%
Change (1 day)
15.14%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2023: C$1.42 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are C$14.47 Billion. In 2023 the company made an earning of C$1.42 Billion a decrease over its 2022 earnings that were of C$1.80 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2023

Annual earnings

Year Earnings Change
2023C$1.42 B-20.93%
2022C$1.80 B-12.7%
2021C$2.06 B-19.92%
2020C$2.57 B13.9%
2019C$2.26 B52.07%
2018C$1.48 B11.22%
2017C$1.33 B-36.03%
2016C$2.09 B31.15%
2015C$1.59 B
2013C$3.30 B33.52%
2012C$2.47 B-4.65%
2011C$2.59 B45.53%
2010C$1.78 B